SCHEMBL25540306

SCHEMBL25540306

Cc1c(C(C)C)nn2c(C)c(C(C)C)nc2c1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25467673 0.66 KDM4E (0.36)
SCHEMBL13054401 0.62 GCGR (0.36)
SCHEMBL14226085 0.61 ALDH1A1 (0.32)
SCHEMBL12415261 0.61 ALDH1A1 (0.49)
SCHEMBL12775549 0.61 KMT2A (0.37)
SCHEMBL12904544 0.59
SCHEMBL12368444 0.58 LMNA (0.36)
SCHEMBL15071356 0.58 ADORA2A (0.34)
SCHEMBL18223396 0.57 PDE10A (0.38)
SCHEMBL24081519 0.57

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230151001-A9 IMIDAZOPYRIDINE DERIVATIVES AND AZA-IMIDAZOPYRIDINE DERIVATIVES AS JANUS KINASE 2 INHIBITORS AND USES THEREOF DANA-FARBER CANCER INSTITUTE, INC. (US) 2023-05-18 US disclosed